Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism
Marcus W. Meinhardt, Simone Pfarr, Grégory Fouquet, et al.
Science Advances (2021) Vol. 7, Iss. 47
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder
Michael P. Bogenschutz, Stephen Ross, Snehal Bhatt, et al.
JAMA Psychiatry (2022) Vol. 79, Iss. 10, pp. 953-953
Open Access | Times Cited: 422
Mini-review: The neurobiology of treating substance use disorders with classical psychedelics
Marvin M. Urban, Moritz R. Stingl, Marcus W. Meinhardt
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 40
Psychedelic therapy in the treatment of addiction: the past, present and future
Rayyan Zafar, Maxim Siegel, Rebecca Harding, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 38
Therapeutic mechanisms of psychedelics and entactogens
Boris D. Heifets, David E. Olson
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 104-118
Closed Access | Times Cited: 29
Psilocybin sex-dependently reduces alcohol consumption in C57BL/6J mice
Kenneth Alper, Janelle Cange, Ria Sah, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 26
The ReCoDe addiction research consortium: Losing and regaining control over drug intake—Findings and future perspectives
Rainer Spanagel, Patrick Bach, Tobias Banaschewski, et al.
Addiction Biology (2024) Vol. 29, Iss. 7
Open Access | Times Cited: 12
A new module in the drug development process: preclinical multi-center randomized controlled trial of R-ketamine on alcohol relapse
Marcus W. Meinhardt, Ivan Skorodumov, Jérôme Jeanblanc, et al.
Neuropsychopharmacology (2025)
Open Access | Times Cited: 1
Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective
John R. Kelly, Claire M. Gillan, Jack Prenderville, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 51
Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies
Javier Calleja‐Conde, José Á. Morales-García, Víctor Echeverry‐Alzate, et al.
Addiction Biology (2022) Vol. 27, Iss. 6
Open Access | Times Cited: 31
Beyond the 5-HT2AReceptor: Classic and Nonclassic Targets in Psychedelic Drug Action
Lindsay P. Cameron, Joseph Benetatos, Vern Lewis, et al.
Journal of Neuroscience (2023) Vol. 43, Iss. 45, pp. 7472-7482
Open Access | Times Cited: 22
Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism
Kevin Domanegg, Wolfgang H. Sommer, Marcus W. Meinhardt
Cells (2023) Vol. 12, Iss. 6, pp. 963-963
Open Access | Times Cited: 18
Psilocybin for the treatment of Alzheimer’s disease
Siyi Zheng, Rong Ma, Yang Yang, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 7
Animal Models of Excessive Alcohol Consumption in Rodents
Howard C. Becker, Marcelo F. Lopez
Current topics in behavioral neurosciences (2024)
Closed Access | Times Cited: 6
Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder
Sophie Köhne, Thomas Hillemacher, Alexander Glahn, et al.
Expert Opinion on Emerging Drugs (2024) Vol. 29, Iss. 3, pp. 219-232
Closed Access | Times Cited: 6
Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice
Nicole Fadahunsi, Jens Lund, Alberte Wollesen Breum, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 26
Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders
Andreas B. Wulff, Charles D. Nichols, Scott M. Thompson
Neuropharmacology (2023) Vol. 231, pp. 109504-109504
Open Access | Times Cited: 14
Synaptic Effects Induced by Alcohol
David M. Lovinger, Marisa Roberto
Current topics in behavioral neurosciences (2023)
Closed Access | Times Cited: 13
Analysis of Psilocybin-Assisted Therapy in Medicine: A Narrative Review
Shawn Ziff, Benjamin Stern, Gregory D. Lewis, et al.
Cureus (2022)
Open Access | Times Cited: 22
From a systems view to spotting a hidden island: A narrative review implicating insula function in alcoholism
Wolfgang H. Sommer, Santiago Canals, Angelo Bifone, et al.
Neuropharmacology (2022) Vol. 209, pp. 108989-108989
Closed Access | Times Cited: 19
Gut Microbiome-Liver-Brain axis in Alcohol Use Disorder. The role of gut dysbiosis and stress in alcohol-related cognitive impairment progression: possible therapeutic approaches.
Emilio Merlo Pich, Ioannis Tarnanas, Patrizia Brigidi, et al.
Neurobiology of Stress (2025) Vol. 35, pp. 100713-100713
Open Access
Exploring factors associated with the intensity of a mystical experience following naturalistic psychedelic use: A retrospective survey
Bruno Roméo, E. Kervadec, Baptiste Fauvel, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111300-111300
Closed Access
Single-dose psilocybin therapy for alcohol use disorder: Pharmacokinetics, feasibility, safety and efficacy in an open-label study
Mathias E. Jensen, Dea Siggaard Stenbæk, Catharina Messell, et al.
Journal of Psychopharmacology (2025)
Open Access
Species differences in comorbid alcohol use disorder and major depressive disorder: A narrative review
Garrett Winkler, Nicholas J. Grahame
Alcohol Clinical and Experimental Research (2025)
Open Access
Exploring novel therapeutic strategies: Could psychedelic perspectives offer promising solutions for Alzheimer’s disease comorbidities?
Michael Davidson, Gabriela Dumitrița Stanciu, Jonathan Rabinowitz, et al.
Dialogues in Clinical Neuroscience (2025) Vol. 27, Iss. 1, pp. 1-12
Open Access
Chronic ethanol exposure produces sex-dependent impairments in value computations in the striatum
Yifeng Cheng, Robin Magnard, Angela J. Langdon, et al.
Science Advances (2025) Vol. 11, Iss. 14
Closed Access
Page 1 - Next Page

Scroll to top